Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Questionable

Statistics show a 90% chance that the patents will be revalidated by the PTO. We have seen that Charles Moore the inventor was able to reverse all original rejections on the 148. The 336 rejections are for the first time and the new rejections on the 148 are new. I have confidence that Moore will be able to reverse the rejections as he did once already. The guy knows his stuff and I have confidence in him. We have heard from some very inteligent people on this forum who have provided there take on the rejections. So to answer your question, yes it would be nice to get an IEE's opinion just to ease some tention and calm down some investers that are starting to panic when PTSC is so close to jumping the biggest hurdle.

IMO and I'm not trying to influence anyone in buying or selling this stock right now, but I like our odds of coming out of the USPTO with stronger patents that will be harder for infringing companies to fight. The USPTO is where we want the fight to be for validity of the patents not in court. We see signs of some companies like Bosch recognizing that the MMP strength will more than likely prevail and they are purchasing licenses before the PTO process is complete as they know Dan Leckrone said that those companies who wait will pay more once the patents are revalidated.

I wish I was just finding this company with what I invested already. I also wish that I would have paid more attention to the smart money (Swartz selling) to protect my investment. I like many here were caught up in the possibilities too soon as it turned out due to Swartz selling, the length of the USPTO reexamination process and the mishandling of the license money and lack of leadership by David Pohl has put the SP in the situation it's in.

I have been impressed with Rick Goerner for what he has accomplished in the short time as CEO. It is obvious he reads these message boards and with all the complaining he knows the disatisfation of shareholders concerning many issues including the old BOD members that hired him. I just hope he does not get discouraged and leaves because when the patents are revalidated he is going to make the right decisions for the company and shareholders. If I didn't believe that all these things were probable I probably wouldn't be here.

Unfortunately many of us made the decision to hold long on this stock too soon and the run-up to $2.25 was premature. We all know that now. For those that sold at a profit good for you.

After waiting so long for PTSC we are anxious for everything to fall into place. Unfortunately the key that unlocks our potential is associated with a government agency that we have no control over. The ball is in TPL's court now regarding their response to the patent office rejections. We all know that PTSC for all its past faults does have a lot of potential and a good foundation to build from. Yes, the foundation could have been $30,000,000 better, but that is water under the bridge.

TPL has done an excellent job so far bringing companies to license the portfolio and are following their plan they laid out and as Goerner said the licensing activity is alive and well. We have to listen and believe in what he says. If we dont trust him or his abilities to lead PTSC to a higher SP then you probably shouldn't be here.

IMO the future is very promising and I'm not concerned about the PTO review process. The patent validity issue is being argued in the right place. Patience is required now.

Sorry for the long post.

All the best,

Steve



Share
New Message
Please login to post a reply